What are the recommended antibiotics for the treatment of pyelonephritis (infection of the kidney)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For uncomplicated pyelonephritis in adults, the recommended first-line antibiotic treatment is oral ciprofloxacin 500 mg twice daily for 7 days, as supported by the most recent guidelines from the European Association of Urology in 2024 1.

Key Considerations

  • The choice of antibiotic should be based on local resistance patterns and the severity of the infection.
  • For more severe cases or patients unable to tolerate oral medications, initial intravenous therapy may be necessary, with options including ceftriaxone, gentamicin, or piperacillin-tazobactam.
  • It is crucial to obtain urine cultures before starting antibiotics to guide therapy and adjust treatment based on culture results and local resistance patterns.
  • Ensure adequate hydration and pain management, and follow-up urine cultures are recommended 1-2 weeks after completing treatment to confirm cure.

Antibiotic Options

  • Oral ciprofloxacin 500 mg twice daily for 7 days
  • Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 14 days if the pathogen is known to be susceptible
  • Intravenous options:
    • Ceftriaxone 1-2 g IV once daily
    • Gentamicin 5 mg/kg IV once daily
    • Piperacillin-tazobactam 3.375 g IV every 6 hours

Rationale

The European Association of Urology guidelines from 2024 recommend fluoroquinolones and cephalosporins as the only antimicrobial agents for oral empiric treatment of uncomplicated pyelonephritis 1. Ciprofloxacin is preferred due to its excellent urinary tract penetration and broad spectrum of activity against gram-negative bacteria. The guidelines also emphasize the importance of obtaining urine cultures and adjusting treatment based on culture results and local resistance patterns.

From the FDA Drug Label

14.7 Complicated Urinary Tract Infections and Acute Pyelonephritis: 5 Day Treatment Regimen To evaluate the safety and efficacy of the higher dose and shorter course of levofloxacin, 1109 patients with cUTI and AP were enrolled in a randomized, double-blind, multicenter clinical trial conducted in the U.S. from November 2004 to April 2006 comparing levofloxacin 750 mg I. V. or orally once daily for 5 days (546 patients) with ciprofloxacin 400 mg I. V. or 500 mg orally twice daily for 10 days (563 patients).

The recommended antibiotics for the treatment of pyelonephritis (infection of the kidney) are:

  • Levofloxacin: 750 mg orally once daily for 5 days 2
  • Ciprofloxacin: 400 mg I.V. or 500 mg orally twice daily for 10 days 2

From the Research

Recommended Antibiotics for Pyelonephritis

The following antibiotics are recommended for the treatment of pyelonephritis:

  • Fluoroquinolones, such as ciprofloxacin or levofloxacin, are commonly used for outpatient treatment 3, 4, 5
  • Aminoglycosides, such as gentamicin, or cephalosporins, such as ceftriaxone, may be used for inpatient treatment 3
  • Trimethoprim-sulfamethoxazole (TMP-SMX) may be an alternative option for a 7-day course, with similar effectiveness to ciprofloxacin 6

Treatment Duration

The recommended treatment duration for pyelonephritis varies:

  • A 7-day course of ciprofloxacin or levofloxacin may be sufficient for outpatient treatment 4, 5
  • A 7-day course of TMP-SMX may be as effective as a 7-day course of ciprofloxacin 6
  • Extended-release ciprofloxacin (1,000 mg once daily) for 7-14 days may be an option for complicated urinary tract infections or acute uncomplicated pyelonephritis 7

Considerations

When selecting an antibiotic, consider the following:

  • Resistance rates in the community: if the resistance rate exceeds 10%, an initial intravenous dose of ceftriaxone or gentamicin may be recommended, followed by an oral fluoroquinolone regimen 3
  • Patient factors, such as severity of illness, pregnancy, or dialysis dependency, may influence the choice of antibiotic and treatment duration 3, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.